🇺🇸 FDA
Pipeline program

infloran

DMR94-IRB-14

Phase 2 other terminated

Quick answer

infloran for Enterocolitis, Necrotizing is a Phase 2 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Enterocolitis, Necrotizing
Phase
Phase 2
Modality
other
Status
terminated

Clinical trials